Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Mixture of seven synthetic fragments consisting of p21 RAS peptides

EU orphan designation number: EU/3/11/885   
Active ingredient: Mixture of seven synthetic fragments consisting of p21 RAS peptides
Indication: Treatment of pancreatic cancer
Sponsor: Targovax AS
Radiumhospitalets Forskningsstiftelse, Vollsveien 6, N-1366 Lysaker, Norge

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
09/08/2011 Orphan designation EMA/OD/007/11 (2011)5810 of 05/08/2011